The site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Two-color flow cytometric analysis of CD79b expression on human peripheral blood lymphocytes. Whole blood was stained with PE Mouse Anti-Human CD79b (Cat. No. 555679/561943) and FITC Mouse Anti-Human CD19 (Cat. No. 555412/560994). Erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 555899).The two color fluorescence dot plot was derived from gated events with the forward and side light-scattering characteristics of viable lymphocytes. Flow cytometry was performed on a BD FACScan™.
Two-color flow cytometric analysis of CD79b expression on human peripheral blood lymphocytes. Whole blood was stained with PE Mouse Anti-Human CD79b (Cat. No. 555679/561943) and FITC Mouse Anti-Human CD19 (Cat. No. 555412/560994). Erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 555899).The two color fluorescence dot plot was derived from gated events with the forward and side light-scattering characteristics of viable lymphocytes. Flow cytometry was performed on a BD FACScan™.
Two-color flow cytometric analysis of CD79b expression on human peripheral blood lymphocytes. Whole blood was stained with PE Mouse Anti-Human CD79b (Cat. No. 555679/561943) and FITC Mouse Anti-Human CD19 (Cat. No. 555412/560994). Erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 555899).The two color fluorescence dot plot was derived from gated events with the forward and side light-scattering characteristics of viable lymphocytes. Flow cytometry was performed on a BD FACScan™.
Two-color flow cytometric analysis of CD79b expression on human peripheral blood lymphocytes. Whole blood was stained with PE Mouse Anti-Human CD79b (Cat. No. 555679/561943) and FITC Mouse Anti-Human CD19 (Cat. No. 555412/560994). Erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 555899).The two color fluorescence dot plot was derived from gated events with the forward and side light-scattering characteristics of viable lymphocytes. Flow cytometry was performed on a BD FACScan™.
Two-color flow cytometric analysis of CD79b expression on human peripheral blood lymphocytes. Whole blood was stained with PE Mouse Anti-Human CD79b (Cat. No. 555679/561943) and FITC Mouse Anti-Human CD19 (Cat. No. 555412/560994). Erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 555899).The two color fluorescence dot plot was derived from gated events with the forward and side light-scattering characteristics of viable lymphocytes. Flow cytometry was performed on a BD FACScan™.
Two-color flow cytometric analysis of CD79b expression on human peripheral blood lymphocytes. Whole blood was stained with PE Mouse Anti-Human CD79b (Cat. No. 555679/561943) and FITC Mouse Anti-Human CD19 (Cat. No. 555412/560994). Erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 555899).The two color fluorescence dot plot was derived from gated events with the forward and side light-scattering characteristics of viable lymphocytes. Flow cytometry was performed on a BD FACScan™.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Immunoglobulin (Ig) antigen receptors are composed of a non-covalently-associated complex of Ig and two other proteins, Igα and Igβ, which have been designated in the Fifth International Leukocyte Workshop as CD79a and CD79b respectively. The CB3-1 monoclonal antibody specifically binds to CD79b, which is expressed on surface Ig (sIg)-positive lymphocytes and B-cell lines but only in the cytoplasm of sIg-negative cells including most terminal deoxynucleotidyl transferase (TdT) positive early pre-B and all cytoplasmic µ positive pre-B cell lines. Antibodies to CD79b are helpful in delineating signal transduction pathways activated via antibody receptors during different stages of B-cell differentiation.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.